Robert J. Flanagan is Director at Sagent Pharmaceuticals, Inc. (SGNT). They have made 13 open-market trades across 4 companies since 2006, most recently 2026-07-01.
CIK 0001251512
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
7 open-market purchases totalling $1.4M since 2006, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| WPC | BUY | 2020-03-03 | 2020-03-05 | $82.29 | $82K | -22.0% | -31.7% | -18.9% |
| SGNT | SELL · 10b5-1 | 2014-10-22 | 2014-10-23 | $31.99 | $256K | N/A | N/A | N/A |
| SGNT | SELL · 10b5-1 | 2014-10-07 | 2014-10-08 | $31.56 | $505K | N/A | N/A | N/A |
| SGNT | SELL · 10b5-1 | 2014-09-24 | 2014-09-25 | $30.01 | $480K | N/A | N/A | N/A |
| SGNT | SELL · 10b5-1 | 2014-09-11 | 2014-09-12 | $28.30 | $453K | N/A | N/A | N/A |
| SGNT | SELL · 10b5-1 | 2014-08-27 | 2014-08-29 | $27.19 | $435K | N/A | N/A | N/A |
| SGNT | SELL · 10b5-1 | 2014-08-11 | 2014-08-13 | $24.39 | $390K | N/A | N/A | N/A |
| SGNT | SELL · 10b5-1 | 2014-07-30 | 2014-07-31 | $25.60 | $410K | N/A | N/A | N/A |
| SGNT | SELL | 2014-07-17 | 2014-07-21 | $26.18 | $419K | N/A | N/A | N/A |
| SGNT | SELL | 2014-07-01 | 2014-07-02 | $26.51 | $424K | N/A | N/A | N/A |
| SGNT | SELL | 2014-06-17 | 2014-06-18 | $23.37 | $374K | N/A | N/A | N/A |
| SGNT | SELL | 2014-06-03 | 2014-06-04 | $22.17 | $355K | N/A | N/A | N/A |
| SGNT | SELL | 2014-05-22 | 2014-05-23 | $22.02 | $176K | N/A | N/A | N/A |
| SGNT | SELL | 2013-09-16 | 2013-09-18 | $20.03 | $10.0M | N/A | N/A | N/A |
| SGNT | BUY | 2011-11-23 | 2011-11-23 | $20.18 | $20K | N/A | N/A | N/A |
| SGNT | BUY | 2011-08-15 | 2011-08-17 | $19.85 | $40K | N/A | N/A | N/A |
| ROX | BUY | 2007-05-08 | 2007-05-10 | $5.97 | $1.0M | -2.4% | -0.8% | -0.8% |
| MATK | BUY | 2006-09-12 | 2006-09-12 | $21.48 | $54K | N/A | N/A | N/A |
| MATK | BUY | 2006-09-11 | 2006-09-11 | $20.84 | $52K | N/A | N/A | N/A |
| ROX | BUY | 2006-04-10 | 2006-04-12 | $9.00 | $180K | -2.4% | -0.8% | -0.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.